The Houston-based company, which develops controllable cellular immunotherapies for cancers and orphan inherited blood disorders, said that the three cases of encephalopathy are thought to be possibly related
TAK-426 is a purified, inactivated, alum-adjuvanted and whole Zika virus vaccine candidate. Zika holds capacity to induce congenital Zika syndrome (CZS), including microcephaly and other congenital brain abnormalities,
Sanofi has offered €45 for each of the shares of Ablynx in an all-cash deal. The acquisition will help Sanofi advance the transformation of its research and development
GEP-NET is a form of cancer that affects the pancreas or gastrointestinal tract. The approval is for adult patients with somatostatin receptor-positive GEP-NETs and it covers conditions like foregut, midgut,
REX-001 has been shown to trigger the growth of new blood vessels to replenish blood supply to the limb, reduce symptoms and boost quality of life of patients
Eli Lilly has developed Solanezumab, which is a monoclonal antibody-based treatment for Alzheimer’s disease. Researchers have projected that Alzheimer’s disease is caused by the development of a sticky
The randomized, double-blind REFLECTIONS B3281006 clinical trial assessed the efficacy, safety, pharmacokinetics and immunogenicity of PF-05280586 in comparison to rituximab. It demonstrated equivalence of the biosimilar candidate in
FlexFactory, which is a biomanufacturing platform based on single-use technologies, will be deployed at Clover’s facility in Changxing of Zhejiang. The facility is being built for the production of biological
MPS IIIA, a rare metabolic disorder also known as Sanfilippo syndrome type A, affects children from an early age. The condition results in severe deterioration of the central nervous
Bioverativ, which is a spin-off from biotech firm Biogen, focuses on therapies for hemophilia and other rare blood disorders. As per the merger deal terms, Sanofi will start
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.